Gene · 10225
Papers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,736
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological significance of extracellular vesicles in innate immune system. | Innate Immun | 2025 | 40583728 | PubTator, text mining | PubMed |
| Multi-omics exploration of CAV1+ tumor epithelial subcelltype in oral squamous cell carcinoma and its impact on the immune microenvironment. | Discov Oncol | 2025 | 40471478 | PubTator, text mining | PubMed |
| scRNA-seq reveals chemotherapy-induced tumor microenvironment changes in pancreatic ductal adenocarcinoma. | Transl Cancer Res | 2025 | 40386264 | PubTator, text mining | PubMed |
| TIGIT deficiency promotes autoreactive CD4+ T-cell responses through a metabolic‒epigenetic mechanism in autoimmune myositis. | Nat Commun | 2025 | 40374622 | PubTator, text mining | PubMed |
| Prognostic and diagnostic value of PVR gene and protein levels, serum amylase, and urinary IGFBP-7 and TIMP-2 biomarkers in multiple myeloma. | BMC Cancer | 2025 | 40369504 | PubTator, text mining | PubMed |
| Predictors of Immunogenicity and Loss of Response to ANTI-TNFα Therapy in Crohn Disease-A Systematic Review. | Am J Ther | 2025 | 40338684 | PubTator, text mining | PubMed |
| Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma. | Front Oncol | 2025 | 40231264 | PubTator, text mining | PubMed |
| Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. | J Clin Invest | 2025 | 40091833 | PubTator, text mining | PubMed |
| PVR exposure influences the activation, adhesion, and protein expression of human CD8+ T cells, including the CD96-mediated transfer of PVR. | J Immunol | 2025 | 40073261 | PubTator, text mining | PubMed |
| CD96: immunoregulation and its role and prospect in immunotherapy of primary hepatocellular carcinoma. | Eur J Gastroenterol Hepatol | 2025 | 39976070 | PubTator, text mining | PubMed |
| Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients. | Int J Immunopathol Pharmacol | 2025 | 39959979 | PubTator, text mining | PubMed |
| Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis. | Ann Rheum Dis | 2025 | 39919905 | PubTator, text mining | PubMed |
| CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96. | J Mol Med (Berl) | 2025 | 39878917 | PubTator, text mining | PubMed |
| Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy. | BMC Biol | 2025 | 39871281 | PubTator, text mining | PubMed |
| Recognition of Self and Viral Ligands by NK Cell Receptors. | Immunol Rev | 2025 | 39748148 | PubTator, text mining | PubMed |
| A study of the association of vitamin D receptor (VDR) as a predictive biomarker for immune checkpoint inhibitor therapy with immune invasion in colon adenocarcinoma. | J Pharm Biomed Anal | 2025 | 39378759 | PubTator, text mining | PubMed |
| Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT. | Hepatology | 2025 | 38779918 | PubTator, text mining | PubMed |
| A novel necroptosis-related genes signature to predict prognosis and treatment response in bladder cancer. | Front Mol Biosci | 2024 | 39655212 | PubTator, text mining | PubMed |
| Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia. | Front Immunol | 2024 | 39582863 | PubTator, text mining | PubMed |
| Time series analysis combined with transcriptome sequencing to explore characteristic genes and potential molecular mechanisms associated with ultrasound-guided microwave ablation of glioma. | Int J Hyperthermia | 2024 | 39317933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10225/papers?page=5